Diabetes Drugs Help Prevent Heart Attack and Recurring Stroke

Recent researches reveal that Diabetes drug may help prevent heart disease. The complications and series of abnormal body behavior arising from both types of diabetes very often result in heart diseases. 

If the blood glucose (sugar) levels rise to higher than normal, this is a problem of your body for diabetes, also known as hyperglycemia. Of the two forms of diabetes, Type 2 is the most common form which is less harmful and controllable.

When your body does not use insulin properly, that is your body is insulin resistant, this type of diabetes is called Type 2 diabetes. In the beginning, the pancreas makes extra insulin to make up for it. But in the long run the pancreas fails, resulting in not producing enough insulin to keep blood glucose at normal levels. It is a drug commonly type 2, or type 1 diabetes, which is to prevent, delay heart disease in people with diabetes are used to study patients may be prescribed.

diabetes tablets

The leading cause of heart disease is diabetes. More than half of all deaths accounts for heart disease. Metapharamina in therapy is used for reducing the production of glucose by the liver to reduce blood glucose levels in type 2 diabetes. The drug also reduces the risk of type 1 diabetes patients with complications. It is also found that a drug commonly prescribed for Type 2 diabetes patients can also be used to inhibit or delay heart disease in individuals with Type 1 diabetes.

More than half of all fatalities, heart disease is the leading cause of illness in diabetic patients. To lower blood sugar levels by reducing glucose production in the liver, metformin is an inexpensive treatment that is often used for Type 2 diabetes.  The researchers also observed that the drug may also be used to lower the risk of developing this complication for Type 1 diabetic patients. 

Jolanta Weaver, Senior Lecturer at the Newcastle University in Britain said that the research was an exciting step forward as it might have positive clinical implications for patients having increased risk of cardiovascular disease by improving their treatment options.  The stem cells of patients taking metformin were able to promote the repair of the blood vessels and there was an improvement in how vascular stem cells worked.  These were the findings of the clinical trial of a group of researchers of the above stated University. Weaver also added that metformin could routinely be used by patients with Type 1 diabetes to help lower their chances to develop heart disease, by increasing a repair mechanism created by vascular stem cells released from the bone marrow.

When the pancreas does not produce any insulin, a person's blood sugar level becomes too high. This causes the Type 1 diabetes developing in a lifelong autoimmune condition. The research team examined a group of 23 people aged 19-64 who had Type 1 diabetes. These people had been suffering from diabetes for upto 23 years but had no evidence of heart disease.

Metformin was applied to patients for eight weeks at a dose they could tolerate, between one to three tablets a day. The patients were advised to adjust their insulin to keep blood glucose levels safe.  Nine patients within the same age bracket were matched together who took standard insulin treatment and 23 healthy non-diabetic people aged 20-64. The study revealed that all patients in the study had their insulin doses reduced after taking metformin and has not suffered any serious adverse effect.

Metformin may be considered for patients with Type 1 diabetes. These patients may think of considering discussion with their physicians the possibility of adding metformin, even at a very low dose in addition to the insulin that they are taking. But to prevent too low glucose levels, care must to be taken to adjust insulin dose as suggested by the researchers, in the paper published in the journal Cardiovascular Diabetolog.